A system to improve cervical cancer screening and treatment in Kenya
Implementing and Evaluating the Cancer Tracking System (CATSystem): A Systems Level Intervention to Improve Cervical Cancer Screening, Treatment Referral and Follow up in Kenya
NA · University of Kansas Medical Center · NCT06286462
This study is testing a new online tool to see if it can help improve cervical cancer screening and treatment for women in Kenya.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 6600 (estimated) |
| Ages | 16 Years and up |
| Sex | Female |
| Sponsor | University of Kansas Medical Center (other) |
| Locations | 10 sites (Akala and 9 other locations) |
| Trial ID | NCT06286462 on ClinicalTrials.gov |
What this trial studies
The Cancer Tracking System (CATSystem) is a web-based tool designed to enhance cervical cancer screening and treatment adherence in Kenya, where screening rates are critically low. This project aims to evaluate the efficacy, implementation, and cost-effectiveness of the CATSystem through a matched, cluster randomized controlled trial across 10 government hospitals. The study will assess how well the CATSystem improves screening, treatment, referral, and follow-up care for cervical cancer patients. By involving both healthcare providers and patients in its development, the CATSystem seeks to address systemic barriers to effective cervical cancer management.
Who should consider this trial
Good fit: Ideal candidates for this study are women over 16 years of age who have access to a cell phone and are presenting for cervical cancer screening at participating hospitals.
Not a fit: Patients who are greater than 20 weeks pregnant, incarcerated, or unable to provide informed consent due to impaired capacity may not benefit from this study.
Why it matters
Potential benefit: If successful, this system could significantly increase cervical cancer screening rates and improve treatment outcomes for women in Kenya.
How similar studies have performed: Other studies have shown success with similar interventions aimed at improving cancer screening rates, indicating potential for the CATSystem's effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women above 16 years of age * access to a cell phone, * presenting for cervical cancer screening at a study hospital. Exclusion Criteria: * greater than 20 weeks gestation, * incarcerated patients, * women who study staff feel are unable to provide written informed consent due to impaired capacity.
Where this trial is running
Akala and 9 other locations
- Akala Health Center — Akala, Kenya (RECRUITING)
- Bondo Referral Hospital — Bondo, Kenya (RECRUITING)
- Alupe Sub-County Hospital — Busia, Kenya (RECRUITING)
- Busia County Referral Hospital — Busia, Kenya (RECRUITING)
- Khunyangu Sub-County Hospital — Busia, Kenya (RECRUITING)
- Matayos Health Center — Busia, Kenya (RECRUITING)
- Port Victoria Sub-County Hospital — Busia, Kenya (RECRUITING)
- Nambale Sub-County Hospital — Siaya, Kenya (RECRUITING)
- Yala Sub-County Hospital — Siaya, Kenya (RECRUITING)
- Ukwala Sub-County Hospital — Ukwala, Kenya (RECRUITING)
Study contacts
- Principal investigator: Sarah Finocchario-Kessler, PhD — Univer
- Study coordinator: Catherine Wexler, MPH
- Email: cwexler@kumc.edu
- Phone: 913-945-7077
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cervical Cancer, cervical cancer screening, treatment of precancerous lesions, treatment of invasive cervical cancer, referral and retention, system level intervention, eHealth intervention, Kenya